Ignite Creation Date:
2025-12-24 @ 7:37 PM
Ignite Modification Date:
2026-02-12 @ 10:20 AM
Study NCT ID:
NCT01245803
Status:
UNKNOWN
Last Update Posted:
2010-11-23
First Post:
2010-11-22
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Acute Rosuvastatin for Preventing Myocardial Damage in Patients With ACS
Sponsor:
Beijing Anzhen Hospital
Organization:
Study Overview
Official Title:
Acute Rosuvastatin for Preventing Myocardial Damage in Patients With Acute Coronary Syndrome
Status:
UNKNOWN
Status Verified Date:
2010-07
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
AVATAR
Brief Summary:
Rosuvastatin reload may prevent myocardial damage in ACS patients undergoing PCI
Detailed Description:
None
Study Oversight
Has Oversight DMC:
Is a FDA Regulated Drug?:
Is a FDA Regulated Device?:
Is an Unapproved Device?:
Is a PPSD?:
Is a US Export?:
Is an FDA AA801 Violation?: